LS
NVAX icon

Lupo Securities’s Novavax NVAX Stock Holding History

Lupo Securities’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$49K Buy
344
+184
+115% +$41.3K 0.37% 35
2015
Q2 		$36K Sell
160
-176
-52% -$30.9K 0.14% 38
2015
Q1 		$56K Buy
336
+45
+15% +$7.31K 0.09% 130
2014
Q4 		$34.5K Buy
+291
New +$30.4K 0.02% 215

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lupo Securities's NVAX Position: Q3 2015 in Review

Lupo Securities increased its Novavax (NVAX) stake by 115% in Q3 2015, buying an estimated $41.3K and bringing the position to 344 shares worth $49K. The position accounts for 0.37% of the portfolio, ranked #35.

Lupo Securities first reported a position in NVAX in Q4 2014 and has held it in 4 quarters since. The position peaked at $56K in Q1 2015. 190 funds tracked by Wall St. Rank hold NVAX as of Q3 2015.

  • Lupo Securities held 344 shares of Novavax worth $49K as of Q3 2015.
  • Lupo Securities bought 184 Novavax shares in Q3 2015, an estimated $41.3K.
  • Novavax made up 0.37% of Lupo Securities's portfolio in Q3 2015, its #35 holding.
  • Lupo Securities first reported a position in Novavax in Q4 2014 and has held it in 4 quarters since.
  • Lupo Securities's Novavax position peaked at $56K in Q1 2015.
  • 190 funds tracked by Wall St. Rank held Novavax as of Q3 2015.

Based on Lupo Securities's 13F filing for Q3 2015, filed 13 Nov 2015.